The stock of Evolent Health, Inc. (NYSE:EVH) is a huge mover today! The stock decreased 3.40% or $0.525 during the last trading session, reaching $14.925. About 415,245 shares traded. Evolent Health, Inc. (NYSE:EVH) has risen 80.60% since March 14, 2017 and is uptrending. It has outperformed by 63.90% the S&P500.The move comes after 5 months negative chart setup for the $1.16B company. It was reported on Mar, 14 by Barchart.com. We have $14.03 PT which if reached, will make NYSE:EVH worth $69.36M less.
VALLOUREC S.A. ORD ORDINARY SHARES (OTCMKTS:VLOUF) had an increase of 17.16% in short interest. VLOUF’s SI was 1.21 million shares in March as released by FINRA. Its up 17.16% from 1.03M shares previously. With 7,900 avg volume, 153 days are for VALLOUREC S.A. ORD ORDINARY SHARES (OTCMKTS:VLOUF)’s short sellers to cover VLOUF’s short positions. The SI to VALLOUREC S.A. ORD ORDINARY SHARES’s float is 0.45%. It closed at $5.444 lastly. It is down 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.
Vallourec SA, through its subsidiaries, provides tubular solutions primarily for the energy markets and other industrial applications in the European Union, North America, South America, Asia, the Middle East, and internationally. The company has market cap of $2.43 billion. It operates through Seamless Tubes and Specialty Products divisions. It currently has negative earnings. The firm produces hot-rolled seamless carbon and alloy steel tubes for the gas and oil, power generation, chemical and petrochemical, and automotive and mechanical engineering industries, as well as produces stainless steel and titanium tubes.
Analysts await Evolent Health, Inc. (NYSE:EVH) to report earnings on May, 8. They expect $-0.10 EPS, up 61.54% or $0.16 from last year’s $-0.26 per share. After $-0.10 actual EPS reported by Evolent Health, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Among 14 analysts covering Evolent Health (NYSE:EVH), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health had 40 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies maintained the shares of EVH in report on Monday, August 21 with “Buy” rating. On Monday, December 11 the stock rating was maintained by Canaccord Genuity with “Buy”. The stock of Evolent Health, Inc. (NYSE:EVH) earned “Outperform” rating by Wells Fargo on Wednesday, February 28. On Thursday, September 28 the stock rating was maintained by Jefferies with “Buy”. On Wednesday, August 9 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock has “Buy” rating by Cantor Fitzgerald on Friday, November 10. Jefferies maintained the shares of EVH in report on Tuesday, February 13 with “Buy” rating. JP Morgan maintained the shares of EVH in report on Monday, March 14 with “Overweight” rating. The stock of Evolent Health, Inc. (NYSE:EVH) has “Buy” rating given on Wednesday, January 6 by Canaccord Genuity. Robert W. Baird maintained the stock with “Buy” rating in Wednesday, June 14 report.